MedPath

Efficacy of Rikkunshito on Nausea, Vomiting and Anorexia in Patients with Uterus Cancer Treated with Cisplatin plus Paclitaxel - Randomized Phase II Study

Phase 2
Conditions
terus cancer
Registration Number
JPRN-UMIN000011227
Lead Sponsor
Hokkaido University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Female
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with cerebral metastases 2)Patients with double cancer 3)Patients with seizure disorder requiring anticonvulsants 4)Patients with disturbed consciousness 5)Patients with gastrointestinal obstruction 6)Patients with vomiting or nausea with =>CTCAE v4.0 Grade 2 7)Patients participating in any other clinical trial 8)Patients with uncontrollable hypertension 9)Patients with diabetes mellitus treated with insulin, or uncontrollable diabetes mellitus 10)Patients with taking corticosteroid, androgen, progesterone or any other orexigenic medicine 11)Patients treated with opioids 12)Pregnant woman, Nursing woman, and woman not to agree with contraception 13)Patients with infection requiring systemic treatment 14)Patients having body temperature of =>38 degree at the enrollment 15)Patients with psychiatric disorder or any psychiatric symptoms, and considered in ineligible to the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath